SCHEDULE 13G: Health In Tech Insider Tim Johnson Discloses Over 60% Beneficial Ownership Post-IPO

Tim Johnson, a key individual at Health In Tech, Inc., has disclosed a significant beneficial ownership stake of 60.4% in the company's Class A Common Stock following its recent initial public offering.

Summary

• Tim Johnson, an individual associated with Health In Tech, Inc., has filed a Schedule 13G disclosing beneficial ownership of 32,170,448 shares of Class A Common Stock as of December 31, 2024.
• This ownership represents 60.4% of the company's Class A Common Stock, calculated based on 42,369,358 Class A shares outstanding, 1,145,182 restricted shares outstanding, and 9,734,707 shares (including 9,000,000 Class B shares and 734,707 options) deemed outstanding for Johnson's calculation.
• The beneficial ownership comprises various forms of equity, including 22,315,651 shares of Class A Common Stock, 82,500 restricted shares, 37,590 restricted shares, 9,000,000 Class B Common Stock shares (convertible to Class A), 495,000 options, 170,115 options, and 69,592 options.
• A significant portion of these shares and options are subject to vesting schedules tied to continued service with the issuer, with vesting dates extending into 2025 and over two to three years post-IPO.

Sentiment

Score: 7

Explanation: The filing indicates strong insider ownership, which is generally positive as it aligns management's interests with shareholders. However, it's a standard regulatory disclosure and doesn't contain new operational or financial news, hence a neutral-to-positive score.

Positives

• Tim Johnson, a key individual, holds a substantial 60.4% beneficial ownership, indicating strong alignment with shareholder interests and confidence in the company's future.
• The significant insider ownership provides stability and suggests long-term commitment from a major stakeholder.

Risks

• A high concentration of ownership by a single individual (Tim Johnson) could potentially lead to significant control over corporate decisions, which might not always align with the interests of minority shareholders.
• The vesting schedules for a substantial portion of the beneficial ownership are contingent on Tim Johnson's continued service, posing a potential risk if his service were to cease prematurely.

Future Outlook

A significant portion of Tim Johnson's beneficial ownership, including 82,500 restricted shares and 495,000 options, is set to vest on June 24, 2025. Additionally, 37,590 restricted shares and a portion of 170,115 options will vest in equal quarterly installments over two years following the company's initial public offering, contingent on continued service.

Industry Context

This filing is a standard disclosure of significant beneficial ownership by an insider following an Initial Public Offering (IPO). It reflects the ownership structure post-IPO and does not provide broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The high insider ownership by Tim Johnson could be viewed positively, indicating strong commitment and alignment of interests. However, it also implies significant control by a single individual.
• Employees: The vesting schedules tied to continued service for Tim Johnson's equity incentives highlight the importance of key personnel retention.

Next Steps

• Continued service of Tim Johnson with Health In Tech, Inc. to ensure vesting of restricted shares and options.
• Future vesting of 82,500 restricted shares and 495,000 options on June 24, 2025.
• Ongoing quarterly vesting of 37,590 restricted shares and remaining 170,115 options over the next two years.

Key Dates

Recommendation

Keywords

Health In Tech Inc, Tim Johnson, Schedule 13G, Beneficial Ownership, Class A Common Stock, Class B Common Stock, Equity Incentive Plan, Restricted Stock, Stock Options, Insider Ownership, SEC Filing, Corporate Governance, IPO